INTERNATIONAL PATENT: LILING BIOPHARMACEUTICALS CO., LTD., 立凌生物制药（苏州）有限公司 FILES APPLICATION FOR "SINGLE-DOMAIN ANTIBODY TARGETING PRAME POLYPEPTIDE AND USE THEREOF"

Posted On: 2025-03-08

GENEVA, March 8 -- LILING BIOPHARMACEUTICALS CO., LTD. (Unit 701, Building B1, Phase I, Biomedical Industrial Park, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215125), 立凌生物制药（苏州）有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B1楼701单元) filed a patent...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: LILING BIOPHARMACEUTICALS CO., LTD., 立凌生物制药（苏州）有限公司 FILES APPLICATION FOR "SINGLE-DOMAIN ANTIBODY TARGETING PRAME POLYPEPTIDE AND USE THEREOF"